retatrutide phase 2 trial obesity nejm 2023 Research Guide: What the Data Reported (2026) Retatrutide Statistics 2026: Phase 2

GIP, or glucose-dependent insulinotropic polypeptide, is another incretin pathway involved in nutrient response

Some experience positive psychological effects: increased confidence, reduced shame, greater social comfort

Additionally, the medications weight loss effects contribute to improved blood pressure control

Management strategies are largely extrapolated from experience with existing GLP-1 receptor agonists, such as semaglutide and liraglutide, which are licensed and available in the UK

Unlike the SUSTAIN-6 study, this study excluded any patients who had pre-existing proliferative diabetic retinopathy (PDR) prior to initiation of tirzepatide and matched patients with their baseline level of DR or DME

What to Look For in a Quality Online Clinic: Comprehensive medical evaluation should include detailed health history, current medications, and lab work to ensure these medications are safe for you